Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Pharmaceutical Holding Company Ltd (NY: BHVN )

66.05 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15
Open 66.05
Bid (Size) 65.00 (4)
Ask (Size) 77.77 (1)
Prev. Close 66.05
Today's Range 66.05 - 66.05
52wk Range 42.74 - 100.77
Shares Outstanding 65,073,919
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biohaven's Nurtec® ODT Signs as Primary Partner with Rick Ware Racing for 2021 NTT INDYCAR Series Program
Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec® ODT (rimegepant) will be the primary partner for the Rick Ware Racing No. 51 NTT IndyCar Series program. Nurtec ODT's vibrant colors... 
From PR Newswire
National Headache Foundation Survey Shows Majority of People with Migraine are Unable to Control Disease and Dissatisfied with Current Preventive Treatment Options
- 84% of people currently taking a preventive treatment wish there was a better treatment option 
From PR Newswire

Performance

YTD
-19.36%
-19.36%
1 Month
-9.25%
-9.25%
3 Month
-22.68%
-22.68%
6 Month
-28.92%
-28.92%
1 Year
+46.75%
+46.75%

More News

Read More
/C O R R E C T I O N -- Biohaven Pharmaceutical Holding Company Ltd./
From PR Newswire
Biohaven Reports First Quarter 2021 Financial Results and Recent Business Developments
From PR Newswire
Biohaven to Report First Quarter 2021 Financial Results and Recent Business Developments on May 10, 2021
From PR Newswire
Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American Academy of Neurology (AAN) Virtual Annual Meeting
From PR Newswire
Biohaven Announces Preliminary 1Q2021 Net Product Revenue For NURTEC ODT
From PR Newswire
Rick Ware Racing, Biohaven's Nurtec ODT and Nine Line Apparel Honor Fallen Service Members
From PR Newswire
10 Biggest Price Target Changes For Wednesday
Tags EOG AMRN Benzinga
From Benzinga
Biohaven Enrolls First Patient in Phase 2/3 Trial of Oral Zavegepant, Prompting $100 Million Milestone Funding Payment from Royalty Pharma
From PR Newswire
Recap: Biohaven Pharma Q1 Earnings
Tags Market News News BZI/Recaps
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.